Selective inhibitor of ADAM10 metalloprotease
CAS：260264-93-5
分子式：C21H33N3O4
分子量：391.5
纯度：98%
存储：Store at -20°C

Background:

Description:IC50: 5.3 nM (ADAM10)
A Disintegrin and metalloproteinase domain-containing protein 10, also known as ADAM10 or CDw156 or CD156c is a protein that in humans is encoded by the ADAM10 gene. ADAM10 (EC#: 3.4.24.81) is a sheddase, and has a broad specificity for peptide hydrolysis reactions (http://en.wikipedia.org/wiki/ADAM10). GI 254023X, synthesized by GSK, was reported to inhibit ADAM10 100-fold over ADAM17. GI 254023X could reduce constitutive cleavage of fractilkine from ECV-304 transfectants [1].
In vitro: Previusl study reported that compound GI254023X possessed comparable inhibitory potency for ADAM10 only and blocked TACE with more than 100-fold reduced potency [2].
In vivo: To examine the ability of GI254023X to inhibit Hla-mediated endothelial barrier disruption in vivo, mice treated for a 3-day period with GI254023X via intraperitoneal injection were subjected to a Miles assay following subcutaneous injection of recombinant toxin. Resutls showed that although all experimental animals succumbed to the lethal challenge, GI254023X-treated mice were less ill in appearance and demonstrated prolongation of time to death [3].
Clinical trial: GI254023X is currently in the preclinical development and no clinical trial is ongoing..
参考文献
[1] Koichi Yokota, and Shin-Ichiro Nishimura. MMP/ADAM inhibitors: therapeutic potential for psoriasis. Expert Opin. Ther. Patents. 2005;15:421-435
[2] Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, Kallen KJ, Rose-John S, Ludwig A.The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003;102(4):1186-95.
[3] Powers ME, Kim HK, Wang Y, Bubeck Wardenburg J.ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J Infect Dis. 2012;206(3):352-6.